Louise Koopman

Company: Genmab

Job title: Associate Director, Translational Research

Seminars:

Preclinical Comparison of Two CD3xB7H4 bsAbs with Divergent CD3 Affinities for the Treatment of Solid Tumors 1:40 pm

Discussing the impact of CD3 affinity on the trade-off between efficacy and safety in preclinical solid tumor models Exploring how translational insights around antigen expression levels, bystander activity, and tolerability in tumor models may carry over to chronic inflammatory indications Reflection on how learnings from immuno-oncology TCE design may inform safer and more effective strategies…Read more

day: Day Two